RNS Number : 9914C
Science Group PLC
13 October 2025
 

13 October 2025

 

 

Trading Update

 

 

Science Group, the international Professional Services and Systems company delivering innovation through the application of science, technology and engineering, provides a trading update for the 9 months ended 30 September 2025.

 

Science Group released its Interim Results on 28 July 2025 reporting another period of record Adjusted Operating Profit ("AOP"), despite the unpredictable market environment. In addition, the Group realised a substantial exceptional pre-tax gain (£24.0 million) and associated cash inflow resulting from the H1 strategic investment.

 

While business confidence remains subdued in some sectors, in aggregate Science Group has continued to perform as anticipated. In particular, the recovery in R&D services, driven by the Medical sector, is progressing as expected.

 

At 30 September 2025, the Group had gross cash of £77.6 million and net funds of £66.0 million, after payment of the dividend in July (£3.6 million) and the first instalment (£2.5 million) of tax due on the H1 strategic investment gain. In addition, in the year to date, the Company has returned £4.4 million to shareholders through its share buy-back programme.

 

In summary, despite the volatile market conditions, Science Group remains on track to deliver another strong performance for the year ending 31 December 2025 with AOP in line or slightly ahead of the Board's expectations.

 

 

- Ends -

 

For further information:

Science Group plc




Martyn Ratcliffe, Executive Chairman

Jon Brett, Finance Director

Tel: +44 (0) 1223 875 200

 

www.sciencegroup.com 

 


Panmure Liberum (Nomad & Broker)

Nicholas How, Max Jones, John More

Tel : +44 (0) 20 3100 2000

 




 



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTURUNRVKURAAA